vimarsana.com

Latest Breaking News On - Marianne uteng - Page 1 : vimarsana.com

AstronauTx completes £48m series A financing for Alzheimer's disease

AstronauTx completes £48m series A financing for Alzheimer's disease
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.

Denmark
United-kingdom
London
City-of
Danish
Marianne-uteng
Jonathan-tobin
Ruth-mckernan
Novartis-venture-fund
Dementia-fund
Life-sciences
Dementia-discovery-fund

AstronauTx closes £48 million ($61 million) Series A financing to create new treatments for Alzheimer's disease

/PRNewswire/ AstronauTx Ltd. ("AstronauTx"), a biotech company developing novel treatments for Alzheimer s disease and other neurodegenerative disorders,.

London
City-of
United-kingdom
Denmark
Boston
Massachusetts
United-states
Danish
British
Ruth-mckernan
Astronautx-bio
Bill-gates

AstronauTx completes £48M funding for new Alzheimer's therapies

Biotech company, AstronauTx Ltd today (October 9) announced the completion of a £48 million ($61 million) Series A financing.

United-kingdom
Denmark
Danish
Ruth-mckernan
Laurence-barker
Marianne-uteng
Life-sciences
Novartis-venture-fund
Dementia-fund
Dementia-discovery-fund
Bristol-myers-squibb
Technology-fund

Tagworks Pharmaceuticals BV: Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics

Tagworks Pharmaceuticals BV: Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Netherlands
Boston
Massachusetts
United-states
Dublin
Ireland
Nijmegen
Gelderland
Barcelona
Comunidad-autonoma-de-cataluna
Spain
America

Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics

Financing round led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates, and Lightstone Ventures.

Boston
Massachusetts
United-states
Spain
Netherlands
Barcelona
Comunidad-autonoma-de-cataluna
Nijmegen
Gelderland
Dublin
Ireland
America

vimarsana © 2020. All Rights Reserved.